COMMUNIQUÉS West-GlobeNewswire

Abeona Therapeutics reçoit la désignation « Fast Track » de la FDA pour la thérapie génique ABO‑202 AAV9 dans la maladie CLN1
19/06/2019
NEW YORK et CLEVELAND, 19 juin 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), chef de file entièrement intégré dans la thérapie génique et cellulaire, a annoncé aujourd'hui que la Food and Drug [...]
Fennec Announces Results of Annual Meeting
19/06/2019
RESEARCH TRIANGLE PARK, N.C., June 19, 2019 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14 [...]
MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal
19/06/2019
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) , a leader in specialized, research-driven cannabis extraction and cannabinoid [...]
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
19/06/2019
RANCHO CUCAMONGA, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) today announced that it has entered into a settlement agreement (the “Settlement Agreement”) with Momenta [...]
RAFARMA Adds Blockchain Tech to Cannabis Distribution
19/06/2019
Ljubljana, Slovenia, June 19, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc (OTC: RAFA), a Wyoming Corporation, is pleased to announce an agreement with Aetsoft LLC. Aetsoft is one of the leading developers of [...]
C-RAD announces resignation of board member
19/06/2019
C-RAD announces today that Peter Eidensjö has announced that he resigns from the Company's board of directors, effective June 19, 2019. "On behalf of our board of directors, I thank Peter for his valuable service and [...]
1,767 Orion Corporation A shares converted into B shares
19/06/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 19 JUNE 2019 at 9.30 EEST 1,767 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 1,767 A [...]
ObsEva Progressing Toward U.S. Phase 3 Trial for Nolasiban in IVF Following Recent FDA Meeting
19/06/2019
Geneva, Switzerland and Boston, MA – June 19, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock
19/06/2019
SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced the pricing of [...]
Calithera Biosciences, Inc. Prices Public Offering of 12,500,000 shares of Common Stock
19/06/2019
SOUTH SAN FRANCISCO, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]
Vigil Health Solutions Reports Profitable Fiscal 2019
19/06/2019
VICTORIA, British Columbia, June 18, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) (TSX-VEN: VGL) announces the results of operations for the fiscal year and the fourth quarter, ending March 31, 2019. [...]
Scholar Rock Announces Proposed Public Offering of Common Stock
18/06/2019
CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
Micron Solutions, Inc. Announces Real Estate Sale, Changes to its Board of Directors and Letter from NYSE American
18/06/2019
FITCHBURG, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
SELLAS Life Sciences Announces Closing of $15 Million Public Offering
18/06/2019
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) (“SELLAS” or the “Company”), a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapeutics [...]
Retrophin Announces Cooperative Research and Development Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome
18/06/2019
SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the National Institutes of [...]
Flexion Therapeutics to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
18/06/2019
BURLINGTON, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led [...]
Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019
18/06/2019
BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and MedTech Conference [...]
Adamas Announces Publication and Presentation of a Data Analysis Demonstrating GOCOVRI Reduces Both the Frequency and Duration of Daily Episodes of Troublesome Dyskinesia and OFF in Parkinson’s Disease
18/06/2019
Novel retrospective analysis of GOCOVRI® pooled Phase 3 Parkinson’s disease diary data, presented at the International Association of Parkinsonism and Related Disorders World Congress; June 16-19, 2019; Montreal, [...]
MyoKardia to Present at 2019 BMO Prescriptions for Success Healthcare Conference
18/06/2019
SOUTH SAN FRANCISCO, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious [...]

Pages